COVID-19 has brought the biotechnology industry into sharp focus, but what does the future hold for this industry and the broader healthcare sector?
Kanish Chugh is the Co-Head of Sales at ETF Securities. Kanish has more than nine years’ experience in the investment management industry. Prior to joining ETF Securities he undertook distribution roles at Blackrock and Fidelity Worldwide Investments and was a foundation member of ANZ ETFS, the joint venture between ETF Securities and ANZ. Before entering the investment management industry Kanish worked in the financial media industry at both the Australian Financial Review and Insto publications taking on both sales and editorial responsibilities.
COVID-19 has brought the biotechnology industry into sharp focus, but what does the future hold for this industry and the broader healthcare sector?